#booster

Non-alcoholic fatty liver disease can lead to more severe, potentially fatal liver diseases, including cirrhosis.

Gilead Sciences has released multiple combo tablets that contain the updated tenofovir, which is linked to improved bone and kidney makers.

It took an extra “booster-dose” of the hep A vaccine for HIV-positive men to have an equivalent response to the vaccine as HIV-negative me...